Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Determinants of HIV drug resistance mutations in plasma virus after treatment interruption.

AIDS (London, England) - 2 Dec 2005

Chilton Daniella, Dervisevic Samir, Pillay Deenan, Rider Andrew, Copas Andrew, Miller Rob F, Edwards Simon G

Abstract excerpt

This study examines the utility of resistance testing during treatment interruption, making comparisons with the current IAS guidelines. A total of 188/1279 tests (14%) were performed during treatment interruption; 69/188 tests (36.7%) demonstrated key mutations. Time off therapy and the total number of previous drugs were both significantly associated with the presence of mutations. We conclude that resistance...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance, Multiple, Viral
Share to Genotype

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HIV Infections

Share to Mutation

Share to Regression Analysis

Share to Viral Load

Source

Identifiers

PMID: 16284471
DOI: 10.1097/01.aids.0000194807.81917.50

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Determinants of HIV drug resistance mutations in plasma virus after treatment interruption.PMID 16284471Read ↗

Use of HIV resistance testing after prolonged treatment interruption.Semantic proximity Read ↗

Drug-resistance mutations number and K70R or T215Y/F substitutions predict treatment resumption during guided treatment interruptions.Semantic proximity Read ↗

Immunovirologic consequences and safety of short, non-structured interruptions of successful antiretroviral treatment.Semantic proximity Read ↗

HIV-1-resistant strains during 8-week on 8-week off intermittent therapy and their effect on CD4+ T-cell counts and antiviral response.Semantic proximity Read ↗

Impaired CD4+ cell recovery during antiretroviral therapy in patients with HIV resistance mutations.Semantic proximity Read ↗

Characterization of associations and development of atazanavir resistance after unplanned treatment interruptions.Semantic proximity Read ↗

Drug resistance guide being pondered by CDC. As HIV drug resistance rises, surveillance needed.Semantic proximity Read ↗

Antiretroviral Treatment Interruptions Predict Female Genital Shedding of Genotypically Resistant HIV-1 RNASemantic proximity Read ↗

Reversal periods and patterns from drug-resistant to wild-type HIV type 1 after cessation of anti-HIV therapy.Semantic proximity Read ↗

Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapySemantic proximity Read ↗

Evolution of HIV-1 genotype in plasma RNA and peripheral blood mononuclear cells proviral DNA after interruption and resumption of antiretroviral therapy.Semantic proximity Read ↗

The natural history and clinical significance of intermittent viraemia in patients with initial viral suppression to < 400 copies/ml.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.